Search

everythinglearnresearchcommunity

for

Search:↓

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

Finasteride reverses early hair loss and promotes growth.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Overweight smokers have worse hair loss.

Hair thickness matters more than density for baldness in Japanese men over 25.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Women with AGA have less hair on midscalp, more thin and non-growing hair.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

FAI values above 6.4 may suggest high androgen levels and increased metabolic risks in Chinese women of reproductive age.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Dutasteride mesotherapy helps treat male hair loss but may harm sperm and sexual function.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.